Charles Schwab Investment Management Inc Precigen, Inc. Transaction History

Charles Schwab Investment Management Inc

  • $519 Billion
  • Q2 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Precigen, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,095,383 shares of PGEN stock, worth $985,844. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,095,383
Previous 1,068,527 2.51%
Holding current value
$985,844
Previous $1.55 Million 11.68%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024
BUY
$1.27 - $1.75 $34,107 - $46,998
26,856 Added 2.51%
1,095,383 $1.73 Million
Q1 2024

May 08, 2024
BUY
$1.21 - $1.75 $71,521 - $103,440
59,109 Added 5.86%
1,068,527 $1.55 Million
Q4 2023

Feb 06, 2024
SELL
$0.89 - $1.41 $45,480 - $72,053
-51,102 Reduced 4.82%
1,009,418 $1.35 Million
Q3 2023

Nov 08, 2023
SELL
$1.08 - $1.85 $40,131 - $68,744
-37,159 Reduced 3.39%
1,060,520 $1.51 Million
Q2 2023

Aug 09, 2023
BUY
$0.96 - $1.4 $60,557 - $88,313
63,081 Added 6.1%
1,097,679 $1.26 Million
Q1 2023

May 11, 2023
BUY
$0.88 - $2.19 $243,906 - $606,993
277,166 Added 36.59%
1,034,598 $1.1 Million
Q4 2022

Feb 13, 2023
BUY
$1.27 - $2.26 $13,851 - $24,649
10,907 Added 1.46%
757,432 $1.15 Million
Q3 2022

Nov 14, 2022
BUY
$1.41 - $2.79 $109,558 - $216,785
77,701 Added 11.62%
746,525 $1.58 Million
Q2 2022

Aug 15, 2022
SELL
$1.15 - $2.53 $62,461 - $137,414
-54,314 Reduced 7.51%
668,824 $897,000
Q1 2022

May 13, 2022
SELL
$1.91 - $3.98 $58,382 - $121,656
-30,567 Reduced 4.06%
723,138 $1.53 Million
Q4 2021

Feb 11, 2022
BUY
$3.53 - $5.5 $54,224 - $84,485
15,361 Added 2.08%
753,705 $2.8 Million
Q3 2021

Nov 16, 2021
BUY
$4.99 - $6.55 $61,945 - $81,311
12,414 Added 1.71%
738,344 $3.69 Million
Q2 2021

Aug 16, 2021
BUY
$6.24 - $8.22 $889,742 - $1.17 Million
142,587 Added 24.44%
725,930 $4.73 Million
Q1 2021

May 17, 2021
BUY
$6.74 - $10.95 $781,381 - $1.27 Million
115,932 Added 24.8%
583,343 $4.02 Million
Q4 2020

Feb 16, 2021
BUY
$3.75 - $10.56 $54,513 - $153,510
14,537 Added 3.21%
467,411 $4.77 Million
Q3 2020

Nov 13, 2020
BUY
$3.5 - $6.2 $2,628 - $4,656
751 Added 0.17%
452,874 $1.59 Million
Q2 2020

Aug 14, 2020
BUY
$2.16 - $5.46 $10,672 - $26,977
4,941 Added 1.1%
452,123 $2.26 Million
Q1 2020

May 15, 2020
BUY
$1.46 - $7.19 $652,885 - $3.22 Million
447,182 New
447,182 $1.52 Million

Others Institutions Holding PGEN

# of Institutions
140
Shares Held
145M
Call Options Held
292K
Put Options Held
53.8K
View Full List

About PRECIGEN, INC.

PGEN Quotes by TradingView
  • Ticker PGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 208,150,000
  • Market Cap $187M
  • Description
  • Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...
More about PGEN
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email